Hypothalamic stress systems in mood disorders
The DOI matches its Crossref record; 108 of the 109 references it cites were found in a registry or an index.
Abstract
Stress system dysfunction is a typical characteristic of acute depression and other mood disorders. The exact pattern of factors predisposing for stress-related mental disorders is yet to be unraveled. However, corticosteroid receptor function plays an important role for appropriate or dysfunctional neuroendocrine responses to stress exposure and hence in resilience or risk for the development and course of both, depression and anxiety disorders. Solid neuroscience data strongly support that both neuropeptides, corticotropin-releasing hormone (CRH) and vasopressin (AVP), are central in coordinating humoral and behavioral adaptation to stress. Other neuropeptides, including oxytocin, neuropeptide S, neuropeptide Y, and orexin, are also considered important contributors. Attempts to turn neuropeptide biology into treatments for stress-related disorders need to consider that neuropeptide receptors are specific drug targets for certain patient populations rather than universal targets for all patients, like biogenic amine systems. That is why most negative clinical trials testing neuropeptide receptor antagonists have been in fact failed trials by design, because no companion tests were used to identify which patients with depression are most likely to benefit from a specific neuropeptide receptor-targeting drug treatment. Therefore, the most important future research task is discovery and development of appropriate companion tests that will allow the successful transfer of the precious treasure of neuropeptide system-targeting drugs into clinics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005
Self-citationHoward, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0326-7 · Cited by 2,565
Reduced Number of Hypocretin Neurons in Human Narcolepsy
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00058-1 · Cited by 2,089
Cited by
The HPA Axis as Target for Depression
Menke, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230811141557 · Cited by 131
“( A higher resolution/colour version of this figure is available in the electronic copy of the article ). blood-brain-barrier [84, 85].”
BackgroundSlabe, Z., Balesar, R. A., Verwer, R. W. H., van Heerikhuize, J. J., Pechler, G. A., Zorović, M., Hoogendijk, W. J. G., & Swaab, D. F. (2023) · Psychological Medicine · doi:10.1017/s0033291723001265 · Cited by 21
“…be involved in depression in AD by stimulation the central release of CRH, in a similar way as proposed for other mood disorders (Bao & Swaab, 2018; Holsboer & Ising, 2021). mRNA Alterations of PACAP and its receptors in the DLPFC and ACC in BD and MDD The PFC is interconnected with the…”
BackgroundResultHu, H., Zarate, C. A., & Verbalis, J. G. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13703 · Cited by 20
“60,62,90 In this context, neuroendocrine markers like AVP have been proposed as biomarkers that may correlate with different depressive phenotypes (e.g., melancholic depression, anxious depression with psychomotor retardation, etc.).”
Papillary Craniopharyngioma: An Integrative and Comprehensive Review
Prieto, R., Juratli, T. A., Bander, E. D., Santagata, S., Barrios, L., Brastianos, P. K., Schwartz, T. H., & Pascual, J. M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae028 · Cited by 19
Wagle, M. D., Zarei, M., Lovett-Barron, M., Poston, K. T., Xu, J., Ramey, V., Pollard, K. S., Prober, D. A., Schulkin, J. A., Deisseroth, K. A., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01567-x · Cited by 17
“Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is observed in mood disorders such as major depression 16–20 .”
Metadata
- Authors
- Holsboer, F., & Ising, M.
- Affiliations
- HolsboerMaschmeyer NeuroChemie (Germany) (DE)
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Florian Holsboer
- Venue
- Handbook of Clinical Neurology
- Publisher
- Elsevier
- Published
- 2021
- Volume
- 182
- Pages
- 33-48
- ISSN
- 0072-9752 (ISSN-L)
- OpenAlex
- W3182876540
- Cited by
- 15
- References
- 109
- Citations by year
- 2025: 5 · 2024: 5 · 2023: 3 · 2022: 2
- FWCI
- 6.25
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Handbook of clinical neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- mood disorders, depression, anxiety disorders, corticosteroid receptors, corticotropin-releasing factor, vasopressin, oxytocin, neuropeptide S, neuropeptide Y, orexin, resilience, stress adaptation, drug target specificity
- MeSH terms
- Corticotropin-Releasing Hormone, Depression, Humans, Neuropeptides, Oxytocin, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypothalamic stress systems in mood disorders. https://app.cochat.ai/papers/10.1016/b978-0-12-819973-2.00003-4
- The paper
- Holsboer, F., & Ising, M. (2021). Hypothalamic stress systems in mood disorders. Handbook of Clinical Neurology. https://doi.org/10.1016/b978-0-12-819973-2.00003-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.